Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030991 · ClinicalTrials.gov registry record
Classification of Heart Failure With Preserved Ejection Fraction
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 514
- Enrollment target
NCT01030991: Completed study, sponsored by Northwestern University.
NCT01030991 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 514 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01030991 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 514 participants
- Enrollment target
Study Summary
The purpose of this study is to create a classification system for the heterogenous disorder of heart failure with preserved ejection fraction (HFpEF).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 514 participants |
| Start Date | 2008-07-01 |
| Est. Completion | 2019-05-21 |
What the finished NCT01030991 record still lists
NCT01030991 is an observational study that tracks outcomes without assigning an intervention. The registered 514 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01030991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01030991 about?
NCT01030991 is a clinical study titled "Classification of Heart Failure With Preserved Ejection Fraction". The purpose of this study is to create a classification system for the heterogenous disorder of heart failure with preserved ejection fraction (HFpEF).
What is the current status of trial NCT01030991?
This trial is currently completed. The enrollment target is 514 participants. The study started on 2008-07-01. Estimated completion is 2019-05-21.
Who is sponsoring clinical trial NCT01030991?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
- NCT06716606 · 514 participants · Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI